Company Research Report: GPx

Company Overview

• Name: GPx (General Prognostics)

• Mission: GPx is focused on improving the lives of individuals with chronic disease via personalized and predictive innovations that are easy for patients to live with and help clinicians deliver the best care. They envision a future where high-quality monitoring is available to everyone, continuously and without invasive clinic visits.

• Founded: No information is available.

• Founders: Sean Matsuoka, Sidhant Jena, Javier Echenique.

• Key People:

• Sean Matsuoka: Co-founder. Experience in marketing at Sony, management consulting at McKinsey & Company, and business development at M3 Inc. and Caresyntax.

• Sidhant Jena: Co-founder and advisor. Previously co-founded a point-of-care diagnostics company and held R&D roles at Medtronic.

• Javier Echenique: Co-founder. Over fifteen years in the medical device industry in various roles.

• Advisors: Dr. Andrew Sauer, Jim Yearick, John Brooks III, Yusuke Tsugawa, Hiro Takeuchi.

• Headquarters: Boston, Massachusetts, USA.

• Number of Employees: No information is available.

• Revenue: No information is available.

• What the Company is Known For: GPx is renowned for innovative healthcare solutions, particularly their "bloodless blood tests" and the CardioID product, leveraging AI algorithms for remote monitoring of heart failure patients.

Products

CardioID

• Product Description: CardioID is GPx's flagship product, designed for continuous and actionable remote monitoring of NT-proBNP biomarkers, aimed at heart failure patients.

• Key Features:

• Provides implant-like accuracy without the need for an implant.

• Enables doctors to monitor patients' blood biomarkers remotely.

• Includes AI algorithm-based predictions to assist in clinical decisions.

Recent Developments

• Recent Developments:

• GPx actively seeks partners for the largest study of their Bloodless Blood Test technology specifically targeting heart failure patients.

• Their Bloodless Blood Test technology has been introduced for remote patient monitoring using wearable IoT technology.

• New Products Launched: No specific new products launched were mentioned.

• New Features Added: No specific new features for existing products were mentioned.

• New Partnerships: In partnership with leading organizations globally for advancing remote disease management.

Achievements and Recognition

• Awards: Winner of the 2022 HLTH and 2023 South by Southwest (SXSW) Startup Pitch Competitions.

• Funding: Raised $3.25 million in seed funding aimed at launching a wearable monitoring device and to develop the world’s first “API for Blood”.

(Note: Only information available in the provided data has been included in the report. "No information is available" is noted for fields with missing data.)